10 Reasons It's Way Too Soon to Give Up on Aurora Cannabis

You might be ready to abandon hope for Aurora Cannabis (NYSE: ACB). That's understandable after the company's ugly fiscal 2020 first-quarter results.

The Canadian cannabis producer's revenue is falling. Its bottom line is deteriorating. Don't let seemingly positive net income resulting from accounting for derivative liabilities fool you on that front. Aurora continues to burn through its cash.

Aurora's path to success might seem next to impossible, but it's way too soon to give up on the company. Here are 10 reasons why. 

Continue reading

Source Fool.com